Condition
Minimally Invasive Coronary Revascularization Surgery clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Minimally Invasive Coronary Revascularization Surgery clinical trials that are recruiting, at sites in 3 countries (most in Switzerland (1), Belgium (1), Netherlands (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Minimally invasive coronary bypass with cangrelor
This study will try giving a short-acting IV antiplatelet drug (cangrelor) during minimally invasive coronary bypass surgery in adults with coronary artery disease to see if it prevents clots without causing extra bleeding.
-
Multivessel Hybrid Revascularization for Three-Vessel CAD vs Conventional Off-Pump CABG
This trial tests whether a minimally invasive multivessel hybrid revascularization (LAD and circumflex grafted via a small thoracotomy plus PCI for the RCA) is better than traditional off-pump CABG done through sternotomy in people with three-vessel coronary disease.
Related topics
Quick answers
How many Minimally Invasive Coronary Revascularization Surgery clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Switzerland (1 trial), Belgium (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.